Clinical studies have found that the active ingredient dihydrotanshinone I in Salvia miltiorrhiza can inhibit GPX4 expression in breast cancer cells, promote ferroptosis, and inhibit tumor growth in mice without significant side effects (102). This evidence concerns the gene GPX4 and breast cancer.